KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsPayablesReal Estate - GrossReal Estate - NetReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Omega Healthcare Investors (OHI) over the last 17 years, with Q4 2025 value amounting to $27.0 million.

  • Omega Healthcare Investors' Cash & Equivalents fell 9478.64% to $27.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $27.0 million, marking a year-over-year decrease of 9478.64%. This contributed to the annual value of $27.0 million for FY2025, which is 9478.64% down from last year.
  • Omega Healthcare Investors' Cash & Equivalents amounted to $27.0 million in Q4 2025, which was down 9478.64% from $737.2 million recorded in Q3 2025.
  • In the past 5 years, Omega Healthcare Investors' Cash & Equivalents registered a high of $737.2 million during Q3 2025, and its lowest value of $6.9 million during Q3 2024.
  • Over the past 5 years, Omega Healthcare Investors' median Cash & Equivalents value was $271.1 million (recorded in 2022), while the average stood at $287.3 million.
  • As far as peak fluctuations go, Omega Healthcare Investors' Cash & Equivalents plummeted by 9876.22% in 2024, and later skyrocketed by 1063676.09% in 2025.
  • Quarter analysis of 5 years shows Omega Healthcare Investors' Cash & Equivalents stood at $20.5 million in 2021, then surged by 1346.88% to $297.1 million in 2022, then skyrocketed by 49.04% to $442.8 million in 2023, then increased by 17.06% to $518.3 million in 2024, then crashed by 94.79% to $27.0 million in 2025.
  • Its Cash & Equivalents stands at $27.0 million for Q4 2025, versus $737.2 million for Q3 2025 and $734.2 million for Q2 2025.